Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo

J Immunol. 2003 May 15;170(10):5008-17. doi: 10.4049/jimmunol.170.10.5008.

Abstract

Repeated exposures to both microbial and innocuous Ags in vivo have been reported to both eliminate and tolerize T cells after their initial activation and expansion. The remaining tolerant T cells have been shown to suppress the response of naive T cells in vitro. This feature is reminiscent of natural CD4(+)CD25(+) regulatory T cells. However, it is not known whether the regulatory function of in vivo-tolerized T cells is similar to the function of natural CD4(+)CD25(+) regulatory T cells. In this study, we demonstrate that CD4(+)CD25(+) as well as CD4(+)CD25(-) T cells isolated from mice treated with superantigen three consecutive times to induce tolerance were functionally comparable to natural CD4(+)CD25(+) regulatory T cells, albeit more potent. The different subpopulations of in vivo-tolerized CD4(+) T cells efficiently down-modulated costimulatory molecules on dendritic cells, and their suppressive functions were strictly cell contact dependent. Importantly, we demonstrate that conventional CD4(+)CD25(-) T cells could also be induced to acquire regulatory functions by the same regimen in the absence of natural regulatory T cells in vivo, but that such regulatory cells were functionally different.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abatacept
  • Animals
  • Antigen-Presenting Cells / immunology
  • Antigen-Presenting Cells / metabolism
  • Antigens, CD
  • Antigens, Differentiation / biosynthesis
  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / metabolism
  • CTLA-4 Antigen
  • Cell Communication / genetics
  • Cell Communication / immunology
  • Cells, Cultured
  • Clonal Anergy / genetics
  • Clonal Anergy / immunology
  • Clonal Deletion / genetics
  • Clonal Deletion / immunology
  • Cytokines / physiology
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / deficiency
  • DNA-Binding Proteins / genetics
  • Dose-Response Relationship, Immunologic
  • Down-Regulation / genetics
  • Down-Regulation / immunology*
  • Drug Administration Schedule
  • Enterotoxins / administration & dosage*
  • Enterotoxins / pharmacology
  • Female
  • Genes, T-Cell Receptor beta / immunology
  • Immunity, Innate / genetics
  • Immunoconjugates*
  • Injections, Intravenous
  • Interleukin-10 / antagonists & inhibitors
  • Interleukin-10 / metabolism
  • Leukocyte Common Antigens / biosynthesis
  • Lymphocyte Activation / genetics
  • Lymphocyte Activation / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, SCID
  • Mice, Transgenic
  • Receptors, Interleukin-2 / biosynthesis*
  • Staphylococcus aureus / immunology
  • Superantigens / administration & dosage*
  • Superantigens / pharmacology
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocyte Subsets / metabolism
  • Transforming Growth Factor beta / antagonists & inhibitors
  • Transforming Growth Factor beta / metabolism
  • Transforming Growth Factor beta / physiology

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • Ctla4 protein, mouse
  • Cytokines
  • DNA-Binding Proteins
  • Enterotoxins
  • Immunoconjugates
  • Rag2 protein, mouse
  • Receptors, Interleukin-2
  • Superantigens
  • Transforming Growth Factor beta
  • V(D)J recombination activating protein 2
  • Interleukin-10
  • enterotoxin A, Staphylococcal
  • Abatacept
  • Leukocyte Common Antigens